3E Extension Study

NCT01834508 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: oral entecavir 0.5mg daily and adefovir 10mg daily for 144 weeks

Sponsor

Nanfang Hospital, Southern Medical University

Collaborators

[object Object]